Dual Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Isoproterenol on Lipid Metabolism and Signaling in Primary Rat Adipocytes

Endocrinology

Volumn 144, Issue 12, 2003, Pages 5293-5299

  Åkesson, Lina ^a,c   Ahrén, Bo ^a   Manganiello, Vincent C ^b   Holst, Lena Stenson ^a   Edgren, Gudrun ^a   Degerman, Eva ^a  

^a LUND UNIVERSITY   (Sweden)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c Biomedical Center C11   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INSULIN; ISOPRENALINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N CYCLOHEXYL 4 (1,2 DIHYDRO 2 OXO 6 QUINOLYLOXY) N (2 HYDROXYETHYL)BUTYRAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHODIESTERASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE INHIBITOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CATABOLISM; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; MALE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ADIPOCYTES; ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG SYNERGISM; ENZYME INHIBITORS; HYPOGLYCEMIC AGENTS; INSULIN; ISOPROTERENOL; ISOQUINOLINES; LIPOLYSIS; MALE; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; SYMPATHOMIMETICS; TRIGLYCERIDES;

EID: 0344825828     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0364     Document Type: Article

References (45)

1. Sherwood NM, Krueckl SL, McRory JE 2000 The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 21:619-670
2. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH 1989 Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-574
3. Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujino M, Minamino N, Arimura A 1990 Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase-activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170:643-648
4. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, Waschek JA 1998 International union of pharmacology. XVII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50:265-270
5. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H 2000 Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52:269-324
6. Ahrén B 1998 Glucagon-like peptide-1 (GLP-1) a gut hormone of potential interest in the treatment of diabetes. Bioessays 20:642-651
7. Filipsson K, Kvist-Reimer M, Ahrén B 2001 The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function. Diabetes 50:1959-1969
8. Fridolf T, Sundler F, Ahrén B 1992 Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse. Cell Tissue Res 269:275-279
9. Filipsson K, Sundler F, Hannibal J, Ahrén B 1998 PACAP and PACAP receptors in insulin producing tissues: localization and effects. Regul Pept 74:167-175
10. Tornoe K, Hannibal J, Fahrenkrug J, Holst JJ 1997 PACAP(1-38) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38). Am J Physiol 273:G436-G446
11. Filipsson K, Holst JJ, Ahrén B 2000 PACAP contributes to insulin secretion after gastric gavage in mice. Am J Physiol Regulatory Integrative Comp Physiol 279:R424-R432
12. Klinteberg KA, Karlsson S, Ahrén B 1996 Signaling mechanisms underlying the insulinotropic effect of pituitary adenylate cyclase-activating polypeptide in HIT-T15 cells. Endocrinology 137:2791-2798
13. + to the insulinotropic action of PACAP 38 in HIT-T15 cells. J Biol Chem 273:32602-32607
14. Gray SL, Cummings KJ, Jirik FR, Sherwood NM 2001 Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol 15:1739-1747
15. Nakata M, Shioda S, Oka Y, Maruyama I, Yada T 1999 Insulinotropin PACAP potentiates insulin-stimulated glucose uptake in 3T3-L1 cells. Peptides 20:943-948
16. Yokota C, Kawai K, Ohashi S, Watanabe Y, Yamashita K 1995 PACAP stimulates glucose output from the perfused rat liver. Peptides 16:55-60
17. Sekiguchi Y, Kasai K, Hasegawa K, Suzuki Y, Shimoda S 1994 Glycogenolytic activity of pituitary adenylate-cyclase activating polypeptide (PACAP) in vivo and in vitro. Life Sci 55:1219-1228
18. Holm C, Langin D, Manganiello V, Belfrage P, Degerman E 1997 Regulation of hormone-sensitive lipase activity in adipose tissue. Methods Enzymol 286:45-67
19. Honnor RC, Dhillon GS, Londos C 1985 cAMP-dependent protein kinase and lipolysis in rat adipocytes. J Biol Chem 260:15130-15138
20. Londos C, Honnor RC, Dhillon GS 1985 cAMP-dependent protein kinase and lipolysis in rat adipocytes. J Biol Chem 260:15139-15145
21. Degerman E, Belfrage P, Manganiello V 1997 Structure, localization and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem 272:6823-6826
22. Degerman E, Rahn Landström T, Stenson Holst L, Göransson O, Ahmad F, Shakur Y, Kenan Y, Manganiello V 2000 A role for phosphodiesterase 3B in the antilipolytic action of insulin. In: LeRoth D, Olefsky JM, Taylor S, eds. Diabetes mellitus: a fundamental and clinical text. Chap 27. Philadelphia: Lippincott Co.; 284-289
23. Rahn T, Ridderstråle M, Tornqvist H, Manganiello V, Fredriksson G, Belfrage P, Degerman E 1994 Essential role of phosphatidylinositol 3-kinase in insulin-induced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes. Studies using the selective inhibitor wortmannin. FEBS Lett 350:314-318
24. Wijkander J, Rahn Landström T, Manganiello V, Belfrage P, Degerman E 1998 Insulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinase. Endocrinology 139:219-227
25. Kitamura T, Kitamura Y, Kuroda S, Hino Y, Ando M, Kotani K, Konishi H, Matsuzaki H, Kikkawa U, Ogawa W, Kasuga M 1999 Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol 19:6286-6296
26. Ahmad F, Cong L, Stenson Holst L, Wang L, Rahn Landström T, Pierce JH, Quon MJ, Degerman E, Manganiello VC 2000 Cyclic nucleotide phosphodiesterase 3B is a downstream target of protein kinase B and may be involved in regulation of effects of protein kinase B on thymidine incorporation in FDCP2 cells. J Immunol 164:4678-4688
27. Wei Y, Mojsov S 1996 Distribution of GLP-1 and PACAP receptors in human tissues. Acta Physiol Scand 157:355-357
28. Honnor RC, Dhillon GS, Londos CJ 1985 cAMP-dependent protein kinase and lipolysis in rat adipocytes. I. Cell preparation, manipulation, and predictability in behavior. J Biol Chem 260:15122-15129
29. Dole V, Neinertz H 1960 Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem 235:2595-2599
30. Moody AJ, Stan MA, Stan M, Glieman J 1974 A simple free fat cell bioassay for insulin. Horm Metab Res 6:12-16
31. Elks ML, Manganiello V 1985 Antilipolytic action of insulin: Role of cAMP phosphodiesterase activation. Endocrinology 116:2119-2121
32. m cAMP phosphodiesterase in rat fat cells by phosphorylation. Proc Natl Acad Sci USA 87:533-537
33. Fain JN, Cowan Jr GS, Buffington C, Li J, Pouncey L, Bahouth SW 2000 Synergism between insulin and low concentrations of isoproterenol in the stimulation of leptin release by cultured human adipose tissue. Metabolism 49:804-809
34. Ridderstråle M, Tornqvist H 1994 PI-3-kinase inhibitor wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes. Biochem Biophys Res Commun 203:306-310
35. Gether U 2000 Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21:90-113
36. i- dependent mechanism. J Biol Chem 274:12017-12022
37. Cao W, Mededev AV, Daniel KW, Collins S 2001 β-Adrenergic activation of p38 MAP kinase in adipocytes. J Biol Chem 276:27077-27082
38. Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, Daniels MB, Chen S, McGarry JD 1996 Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728-2735
39. Ruiz-Grande C, Alarcon C, Merida E, Valverde I 1992 Lipolytic action of glucagon-like peptides in isolated rat adipocytes. Peptides 13:13-16
40. Villanueva-Penacarrillo ML, Marquez L, Gonzalez N, Diaz-Miguel M, Valverde I 2001 Effect of GLP-1 on lipid metabolism in human adipocytes. Horm Metab Res 33:73-77
41. Bertin E, Arner P, Bolinder J, Hagström-Toft E 2001 Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo. J Clin Endocrinol Metab 86:1229-1234
42. Montrose-Rafizadeh C, Yang H, Wang Y, Roth J, Montrose MH, Adams LG 1997 Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes. J Cell Physiol 172:275-283
43. McIntosh CHS, Bremsak I, Lynn FC, Gill R, Hinke SA, Gelling R, Nian C, McKnight G, Jaspers S, Pederson RA 1999 Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin. Endocrinology 140:398-404
44. Yip RGC, Wolfe MM 2000 GIP biology and fat metabolism. Life Sci 66:91-103
45. Filipsson K, Tornoe K, Holst JJ, Ahrén B 1997 Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans. J Clin Endocrinol Metab 82:3093-3098